IMNM
Price
$18.66
Change
+$0.36 (+1.97%)
Updated
Nov 26, 04:30 PM (EDT)
Capitalization
1.68B
113 days until earnings call
Intraday BUY SELL Signals
MRKR
Price
$1.14
Change
+$0.04 (+3.64%)
Updated
Nov 26, 10:37 AM (EDT)
Capitalization
18.34M
Intraday BUY SELL Signals
Interact to see
Advertisement

IMNM vs MRKR

Header iconIMNM vs MRKR Comparison
Open Charts IMNM vs MRKRBanner chart's image
Immunome
Price$18.66
Change+$0.36 (+1.97%)
Volume$300
Capitalization1.68B
Marker Therapeutics
Price$1.14
Change+$0.04 (+3.64%)
Volume$1.1K
Capitalization18.34M
IMNM vs MRKR Comparison Chart in %
IMNM
Daily Signal:
Gain/Loss:
MRKR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IMNM vs. MRKR commentary
Nov 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a StrongBuy and MRKR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 26, 2025
Stock price -- (IMNM: $18.30 vs. MRKR: $1.10)
Brand notoriety: IMNM and MRKR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 55% vs. MRKR: 93%
Market capitalization -- IMNM: $1.68B vs. MRKR: $18.34M
IMNM [@Biotechnology] is valued at $1.68B. MRKR’s [@Biotechnology] market capitalization is $18.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $109.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileMRKR’s FA Score has 1 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • MRKR’s FA Score: 1 green, 4 red.
According to our system of comparison, both IMNM and MRKR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 4 TA indicator(s) are bullish while MRKR’s TA Score has 6 bullish TA indicator(s).

  • IMNM’s TA Score: 4 bullish, 4 bearish.
  • MRKR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MRKR is a better buy in the short-term than IMNM.

Price Growth

IMNM (@Biotechnology) experienced а +2.46% price change this week, while MRKR (@Biotechnology) price change was +8.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.66%. For the same industry, the average monthly price growth was -2.07%, and the average quarterly price growth was +70.84%.

Reported Earning Dates

IMNM is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (+3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($1.68B) has a higher market cap than MRKR($18.3M). IMNM YTD gains are higher at: 72.316 vs. MRKR (-64.630). MRKR has higher annual earnings (EBITDA): -8.09M vs. IMNM (-187.92M). IMNM has more cash in the bank: 268M vs. MRKR (10.5M). MRKR has less debt than IMNM: MRKR (0) vs IMNM (4.14M). IMNM has higher revenues than MRKR: IMNM (12.6M) vs MRKR (6.59M).
IMNMMRKRIMNM / MRKR
Capitalization1.68B18.3M9,169%
EBITDA-187.92M-8.09M2,324%
Gain YTD72.316-64.630-112%
P/E RatioN/AN/A-
Revenue12.6M6.59M191%
Total Cash268M10.5M2,552%
Total Debt4.14M0-
FUNDAMENTALS RATINGS
MRKR: Fundamental Ratings
MRKR
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
44

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMNMMRKR
RSI
ODDS (%)
Bearish Trend 6 days ago
82%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 20 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IMNM
Daily Signal:
Gain/Loss:
MRKR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATLC58.022.64
+4.77%
Atlanticus Holdings Corp
BNGO1.740.06
+3.57%
Bionano Genomics Inc
VIOT2.720.09
+3.42%
Viomi Technology Co Ltd
NWE67.510.74
+1.11%
NorthWestern Energy Group
AXON528.894.29
+0.82%
Axon Enterprise

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-1.88%
IDYA - IMNM
56%
Loosely correlated
+2.37%
IPSC - IMNM
53%
Loosely correlated
+2.31%
ARWR - IMNM
51%
Loosely correlated
+5.72%
NRIX - IMNM
51%
Loosely correlated
-0.87%
RLAY - IMNM
50%
Loosely correlated
-1.47%
More

MRKR and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRKR has been loosely correlated with CDXS. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if MRKR jumps, then CDXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRKR
1D Price
Change %
MRKR100%
-2.65%
CDXS - MRKR
33%
Loosely correlated
+5.66%
NAGE - MRKR
32%
Poorly correlated
+2.62%
XNCR - MRKR
32%
Poorly correlated
+3.11%
BLRX - MRKR
31%
Poorly correlated
+1.43%
IMNM - MRKR
31%
Poorly correlated
-1.88%
More